| Authors: |
Jochmans D; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Virology & Chemotherapy, Leuven, Belgium., Liu C; Aligos Therapeutics, Inc., South San Francisco, California, USA., Donckers K; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Virology & Chemotherapy, Leuven, Belgium., Stoycheva A; Aligos Therapeutics, Inc., South San Francisco, California, USA., Boland S; CISTIM Leuven vzw, Leuven, Belgium., Stevens SK; Aligos Therapeutics, Inc., South San Francisco, California, USA., De Vita C; Aligos Therapeutics, Inc., South San Francisco, California, USA., Vanmechelen B; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Clinical & Epidemiological Virology, Leuven, Belgium., Maes P; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Clinical & Epidemiological Virology, Leuven, Belgium., Trüeb B; Institute of Virology and Immunology, University of Bern, Bern, Switzerland., Ebert N; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Thiel V; Institute of Virology and Immunology, University of Bern, Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., De Jonghe S; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Virology & Chemotherapy, Leuven, Belgium., Vangeel L; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Virology & Chemotherapy, Leuven, Belgium., Bardiot D; CISTIM Leuven vzw, Leuven, Belgium., Jekle A; Aligos Therapeutics, Inc., South San Francisco, California, USA., Blatt LM; Aligos Therapeutics, Inc., South San Francisco, California, USA., Beigelman L; Aligos Therapeutics, Inc., South San Francisco, California, USA., Symons JA; Aligos Therapeutics, Inc., South San Francisco, California, USA., Raboisson P; Aligos Belgium BV, Leuven, Belgium., Chaltin P; CISTIM Leuven vzw, Leuven, Belgium.; Centre for Drug Design and Discovery (CD3), KU Leuven, Leuven, Belgium., Marchand A; CISTIM Leuven vzw, Leuven, Belgium., Neyts J; KU Leuven, Department of Microbiology, Immunology & Transplantation, Rega Institute, Laboratory of Virology & Chemotherapy, Leuven, Belgium.; Global Virus Network (GVN), Baltimore, Maryland, USA., Deval J; Aligos Therapeutics, Inc., South San Francisco, California, USA., Vandyck K; Aligos Belgium BV, Leuven, Belgium. |
